1. Home
  2. AAPG vs RYN Comparison

AAPG vs RYN Comparison

Compare AAPG & RYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • RYN
  • Stock Information
  • Founded
  • AAPG 2009
  • RYN 1926
  • Country
  • AAPG China
  • RYN United States
  • Employees
  • AAPG N/A
  • RYN N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • RYN Real Estate Investment Trusts
  • Sector
  • AAPG Health Care
  • RYN Real Estate
  • Exchange
  • AAPG Nasdaq
  • RYN Nasdaq
  • Market Cap
  • AAPG 3.6B
  • RYN 4.1B
  • IPO Year
  • AAPG 2025
  • RYN N/A
  • Fundamental
  • Price
  • AAPG $39.17
  • RYN $25.97
  • Analyst Decision
  • AAPG Buy
  • RYN Hold
  • Analyst Count
  • AAPG 1
  • RYN 4
  • Target Price
  • AAPG N/A
  • RYN $28.00
  • AVG Volume (30 Days)
  • AAPG 11.9K
  • RYN 918.1K
  • Earning Date
  • AAPG 11-06-2025
  • RYN 11-05-2025
  • Dividend Yield
  • AAPG N/A
  • RYN 10.99%
  • EPS Growth
  • AAPG N/A
  • RYN 389.17
  • EPS
  • AAPG N/A
  • RYN 4.92
  • Revenue
  • AAPG $54,524,554.00
  • RYN $1,239,943,000.00
  • Revenue This Year
  • AAPG N/A
  • RYN N/A
  • Revenue Next Year
  • AAPG $387.72
  • RYN $4.07
  • P/E Ratio
  • AAPG N/A
  • RYN $10.88
  • Revenue Growth
  • AAPG N/A
  • RYN 40.53
  • 52 Week Low
  • AAPG $16.50
  • RYN $21.84
  • 52 Week High
  • AAPG $48.45
  • RYN $32.88
  • Technical
  • Relative Strength Index (RSI)
  • AAPG N/A
  • RYN 49.87
  • Support Level
  • AAPG N/A
  • RYN $26.02
  • Resistance Level
  • AAPG N/A
  • RYN $26.80
  • Average True Range (ATR)
  • AAPG 0.00
  • RYN 0.47
  • MACD
  • AAPG 0.00
  • RYN -0.12
  • Stochastic Oscillator
  • AAPG 0.00
  • RYN 23.66

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About RYN Rayonier Inc. REIT

Rayonier owns and manages over 2 million acres of timberland in the United States. It is one the largest private landowners in North America. Rayonier is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities.

Share on Social Networks: